Adverse Effects of Biologic Therapy: A Retrospective Cohort Study
Pharmacoepidemiology · 26.05.2026 · 5 (2) · 15
DOI: 10.3390/pharma5020015 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pharmacoepidemiology, online erschienen am 26.05.2026. Verfasst von Entela Shkodrani und 5 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate adverse effects associated with biologic therapy (Etanercept, Adalimumab, and Secukinumab) in patients with psoriasis, psoriatic arthritis, and hidradenitis suppurativa.
Methods
This retrospective observational study included 58 patients receiving biologic therapy: 40 with generalized plaque psoriasis, 13 with psoriatic arthritis, and 3 with hidradenitis suppurativa. Eligibility was based on national treatment protocols (Psoriasis Area and Severity Index [PASI] > 10; Hurley stage II–III). Demographic data, treatment duration, therapy modifications, discontinuations, and adverse events were collected from medical records. Patients were monitored for both efficacy and safety outcomes.
Results
Treatment discontinuation due to severe hepatotoxicity occurred in four patients (three receiving Etanercept and one Adalimumab), corresponding to 6.9% of the cohort. Adalimumab was discontinued in one patient due to cutaneous leishmaniasis after 24 months and in another due to pregnancy after 26 months. Upper limb edema was observed following a switch from Adalimumab to Secukinumab. One patient discontinued Etanercept due to lack of efficacy and subsequently died from a fatal methotrexate overdose. Treatment switches included Etanercept to Adalimumab for granulomatous uveitis (one case) and Adalimumab to Etanercept due to generalized urticaria (two cases).
Conclusion
Adverse events were relatively infrequent, with an overall incidence below 10% (6.9% for the most common event and
Zitieren
APA
Shkodrani, E., Ruci, D., Xhaja, A., Serani, K., Shkodrani, B., & Ruci, V. (2026). Adverse Effects of Biologic Therapy: A Retrospective Cohort Study. Pharmacoepidemiology, 5(2), 15. https://doi.org/10.3390/pharma5020015
Vancouver
Shkodrani E, Ruci D, Xhaja A, Serani K, Shkodrani B, Ruci V. Adverse Effects of Biologic Therapy: A Retrospective Cohort Study. Pharmacoepidemiology. 2026;5(2):15. doi:10.3390/pharma5020015
BibTeX
@article{Shkodrani2026,
author = {Shkodrani, Entela and Ruci, Dorina and Xhaja, Alert and Serani, Krisli and Shkodrani, Barbara and Ruci, Viktoria},
title = {Adverse Effects of Biologic Therapy: A Retrospective Cohort Study},
journal = {Pharmacoepidemiology},
year = {2026},
volume = {5},
number = {2},
pages = {15},
doi = {10.3390/pharma5020015}
}
EUVIMED